ArticleNPJ vaccines2026

LNP-based delivery of a Toll-like receptor 9 agonist elicits potent adjuvant effects and antitumor immunity.

Yarong Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.